申请人:Bayer Aktiengesellschaft
公开号:US04853406A1
公开(公告)日:1989-08-01
Thrombocyte aggregation-inhibiting polyhydrobenz[c,d]indolesulphonamide of the formula ##STR1## in which R.sup.1 is hydrogen, aryl or alkyl, R.sup.2 is hydrogen, halogen, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, hydroxyl, aralkoxy or a group of the formula ##STR2## R.sup.3 and R.sup.4 each independently is hydrogen, alkyl, aryl, aralkyl or acyl and X is cyano or carboxyl, and salts thereof. Intermediates therefor of the formula ##STR3## are also new.
公式为##STR1##的抑制血小板聚集的聚氢苯[c,d]吲哚磺酰胺,其中R.sup.1是氢、芳基或烷基,R.sup.2是氢、卤素、烷基、烷氧基、三氟甲基、三氟甲氧基、羟基、芳基氧基或公式##STR2##的基团,R.sup.3和R.sup.4各自独立地是氢、烷基、芳基、芳基烷基或酰基,X是氰基或羧基,以及其盐。其中间体的公式为##STR3##也是新的。